NCT01133847
Interventions for Children With Attention and Reading Disorders
See it on ClinicalTrials.gov ↗216 people
38.9%
61.1%
84 womenmiddle line = equal numbers132 men
- Phase
- PHASE4
- Paid for by
- The University of Texas Health Science Center, Houston
- Finished
- 2015-06
- Health conditions
- Attention Deficit Hyperactivity Disorder, Reading Disabilities
- Who could join
- Anyone
- Ages
- 7 Years – 12 Years
- Average age
- Not reported
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 12 Years.”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“Any documented or suspected bipolar disorder, severe psychosis, or other severe emotional disturbance, developmental disability, or autism.”
Study titles and rules are shown in their original English.